Literature DB >> 29049121

Opioids for the Treatment of Chronic Pain: Mistakes Made, Lessons Learned, and Future Directions.

Jane C Ballantyne1.   

Abstract

An overreliance on opioids has impacted all types of pain management, making it undoubtedly a root cause of the "epidemic" of prescription opioid abuse in the United States. Yet, an examination of the statistics that led the US Centers for Disease Control and Prevention to declare that prescription opioid abuse had reached epidemic levels shows that the abuse occurrences and deaths are arising outside the hospital or hospice setting, which strongly implicates the outpatient use of opioids to treat chronic pain. Such abuse and related deaths are occurring in chronic pain patients themselves and also through diversion. Overprescribing to outpatients has afforded distressed and vulnerable individuals access to these highly addictive drugs. The focus of this article is on what we have learned since opioid treatment of chronic pain was first popularized at the end of the 20th century and how this new information can guide chronic pain management in the future.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29049121     DOI: 10.1213/ANE.0000000000002500

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  33 in total

1.  The Opioid Epidemic and Pain Medicine Specialists: Where to Begin and What Is Next?

Authors:  Reda Tolba; Ehab Meselhy; Carlos E Guerra
Journal:  Ochsner J       Date:  2018

Review 2.  Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settings.

Authors:  Robert Chuck Rich; Roger Chou; Edward R Mariano; Anna Legreid Dopp; Rebecca Sullenger; Helen Burstin
Journal:  NAM Perspect       Date:  2020-08-10

3.  Neuromodulation Management of Chronic Neuropathic Pain in The Central Nervous system.

Authors:  Kai Yu; Xiaodan Niu; Bin He
Journal:  Adv Funct Mater       Date:  2020-06-10       Impact factor: 18.808

Review 4.  Management of Opioid-Tolerant Patients with Acute Pain: Approaching the Challenges.

Authors:  Pamela E Macintyre; Lindy J Roberts; Christine A Huxtable
Journal:  Drugs       Date:  2020-01       Impact factor: 9.546

5.  The Impact of Opioid Epidemic Trends on Hospitalised Inflammatory Bowel Disease Patients.

Authors:  Shirley Cohen-Mekelburg; Russell Rosenblatt; Stephanie Gold; Robert Burakoff; Akbar K Waljee; Sameer Saini; Bruce R Schackman; Ellen Scherl; Carl Crawford
Journal:  J Crohns Colitis       Date:  2018-08-29       Impact factor: 9.071

6.  Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication.

Authors:  Nathan Anderson; Andrea G Gillman; Ajay D Wasan
Journal:  J Pain Res       Date:  2020-05-06       Impact factor: 3.133

7.  The prevalence and awareness of sleep apnea in patients suffering chronic pain: an assessment using the STOP-Bang sleep apnea questionnaire.

Authors:  Gregory S Tentindo; Scott M Fishman; Chin-Shang Li; Qinlu Wang; Steven D Brass
Journal:  Nat Sci Sleep       Date:  2018-08-01

8.  General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.

Authors:  Ruth White; Chris Hayes; Allison W Boyes; Simon Chiu; Christine L Paul
Journal:  J Pain Res       Date:  2019-01-22       Impact factor: 3.133

9.  An Audio-Recorded Hypnosis Intervention for Chronic Pain Management in Cancer Survivors: A Randomized Controlled Pilot Study.

Authors:  Linda H Eaton; Susan L Beck; Mark P Jensen
Journal:  Int J Clin Exp Hypn       Date:  2021-07-26

10.  Effects of hypnosis, cognitive therapy, hypnotic cognitive therapy, and pain education in adults with chronic pain: a randomized clinical trial.

Authors:  Mark P Jensen; Maria Elena Mendoza; Dawn M Ehde; David R Patterson; Ivan R Molton; Tiara M Dillworth; Kevin J Gertz; Joy Chan; Shahin Hakimian; Samuel L Battalio; Marcia A Ciol
Journal:  Pain       Date:  2020-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.